Possibilities of correction of post viral other dysfunction in the application of COVID-19

Introduction. One of the characteristic manifestations of COVID-19 is a disorder of smell, which, according to the literature, occurs in 61.2% - 85.6% of patients with COVID-19. The article discusses the problems of post-viral dysosmia in COVID-19 convalescents. Purpose of the study. Evaluation of olfactory disorders in patients after coronavirus infection and the possibility of obtaining additional benefits from prescribing bioregulatory medicine drugs.

Materials and methods. The assessment of the severity of olfactory disorders in patients, taking into account the age according to self-assessment data using a visual analogue scale, as well as an objective assessment of odor identification using the Sniffin ‘Sticks Screening 12 Test. The possibility of increasing the efficiency of recovery of olfactory disorders by prescribing complex preparations of bioregulatory therapy (main group) was studied.

Results. The percentage of persons who fully restored the olfactory function in the main group was 56.5%, while in the patients of the control group only in 6.6%. Faster (on the 7^th day) dynamics of identification testing using SST-12 in patients taking complex preparations of bioregulation therapy was noted. On the 3rd day of therapy, there was a significant decrease in anxiety in patients treated with bioregulatory drugs.

Discussion. The conducted study objectively confirmed that the olfactory disorder is present in the vast majority of patients with ARS. The appointment of bioregulatory therapy contributes to the early restoration of the olfactory function.

Conclusions. Based on the results of this study, it can be concluded that it is advisable to use bioregulatory drugs.

1. Mendelson M., Nel J., Blumberg L., Madhi S.A., Dryden M., Stevens W., Venter F.W.D. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020;23;111(1):10-12. https://doi.org/10.7196/SAMJ.2020.v111i11.15433.

2. Kryukov A.I., Kazakova A.A., Gekht A.B. Smell impairment in COVID-19 patients: mechanisms and clinical implications. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2020;85(5):93-97. (In Russ.) https://doi.org/10.17116/otorino20208505193.

3. Kapoor D., Verma N., Gupta N., Goyal A. Post viral olfactory dysfunction after SARS-CoV-2 infection: anticipated post-pandemic clinical challenge. Indian J Otolaryngol Head Neck Surg. 2021;1-8. https://doi.org/10.1007/s12070-021-02730-6.

4. Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.I., Ahmad R. Olfactory dysfunction and synonasal symptomatology in COVID-19: prevalence, severity, timing and related characteristics. Sedaghat Otolaryngol Head Neck Surg. 2020;163(1):114-120. https://doi.org/10.1177/0194599820929185.

5. Lechien J.R., Chiesa-Estomba C.M., Siati D.R. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261. https://doi.org/10.1007/s00405-020-05965-1.

6. Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405-407. https://doi.org/10.1136/thoraxjnl-2020-216377.

7. Kosugi E.M., Lavinsky J., Romano F.R., Fornazieri M.A.., Luz-Matsumoto G.R., Lessa M.M. et al. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19. Braz J Otorhinolaryngol. 2020;86(4):490-496. https://doi.org/10.1016/j.bjorl.2020.05.001.

8. Baig A.M. Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome. ACS Chem Neurosci. 2020;11(24):4017-4020. https://doi.org/10.1021/acschemneuro.0c00725.

9. Wijeratne T., Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci. 2020;419:117179. https://doi.org/10.1016/j.jns.2020.117179.

10. Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers. J Med Virol. 2020;93(5):2555-2556. https://doi.org/10.1002/jmv.26624.

11. Kalter L. Fauci Introduces New Acronym for Long COVID at White House Briefing. 2021. Available at: https://www.medscape.com/viewarticle/946419.

12. Chang C.C., Yang M.H., Chang S.M., Hsieh Y.J., Lee C.H., Chen Y.A. et al. Clinical significance of olfactory dysfunction in patients of COVID-19. J Chin Med Assoc. 2021;1;84(7):682-689. https://doi.org/10.1097/JCMA.0000000000000560.

13. Belopasov V.V., Zhuravleva E.N., Nugmanova N.P., Abdrashitova A.T. Postcovid neurological syndromes. Klinicheskaya praktika = Clinical Practice. 2021;12(2):69-82. (In Russ.) https://doi.org/10.17816/clinpract71137.

14. Karapetyan L.S., Svistushkin V.M. Olfactory dysfunction and COVID-19 are the current state of the problem. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2020;85(6):100-104. (In Russ.) https://doi.org/10.17116/otorino202085061100.

15. Varvyanskaya A.V., Lopatin A.S. Manifestations of a new coronavirus infection in the upper respiratory tract. Rossijskaya rinologiya = Russian Rhinology. 2020;28(3):157-163. (In Russ.) https://doi.org/10.17116/rosrino202028031157.

16. Hummel T., Whitcroft K.L., Andrews P., Altundag A., Cinghi C., Costanzo R.M. et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54(26):1-30. https://doi.org/10.4193/Rhino16.248.

17. Bigday E.V., Samoilov V.O. Olfactory dysfunction as an indicator of the early stage of COVID-19 disease. Integrativnaya fiziologiya = Integrative Physiology. 2020;1(3):187-195. (In Russ.) https://doi.org/10.33910/2687-1270-2020-1-3-187-195.

18. Vladimirova T.Yu., Kochetkova A.P., Mosikhin S.B., Ovchinnikov A.Yu., Safina A.I., Safina L.Z., Svistushkin V.M. Resolution of the Council of Experts “Bioregulatory drugs in the complex therapy of common ENT diseases”. Vestnik Otorinolaringologii = Bulletin of Otorhinolaryngology. 2020;85(4):89-92. (In Russ.) https://doi.org/10.17116/otorino20208504189.

19. Ovchinnikov A.Yu., Miroshnichenko N.A., Smirnov I.V. The value of bioregu-latory therapy in the treatment of rhinosinusitis. RMJ. Medical Review. 2019;2(II):51-53. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Znachenie_bioregulyacionnoy_terapii_pri_lechenii_rinosinusita/.

20. Garashchenko T.I., Selkova E.P., Karneeva O.V., Garashchenko M.V., Oganesyan A.S. Bioregulationnaya therapy in the treatment and prevention of upper respiratory tract diseases in children. Medicinskij Sovet = Medical Council. 2020;(18):32-41. (In Russ.) https://doi.org/10.21518/2079-701X-2020-18-32-41.

21. Laurent G.S., Seilheimer B., Tackett M., Zhou J., Shtokalo D., Vyatkin Y. et al. Deep Sequencing Transcriptome Analysis of Murine Wound Healing: Effects of a Multicomponent, Multitarget Natural Product Therapy-Tr14. Front Mol Biosci. 2017;4:57. https://doi.org/10.3389/fmolb.2017.00057.

22. Kirichenko I.M. Bioregulatory drugs in the prevention of complications in the early postoperative period in patients after septoplasty and FESS. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2020;85(3):64-67. (In Russ.) https://doi.org/10.17116/otorino20208503164.

23. Savvateeva D.M., Kochetkov P.A., Lopatin A.S. Influence of surgical and medical treatment on the state of the olfactory function in patients with polyposis rhinosinusitis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2012;77(2):31-35. (In Russ.) Available at: https://www.medias-phera.ru/issues/vestnik-otorinolaringologii/2012/2/030042-4668201226.

24. Zhukova I.A., Zhukova N.G., Izhboldina O.P., Nikitina M.A., Alifirova V.M. Analysis of methods for assessing the sense of smell in patients with Parkinson's disease. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(6-2):44-49. (In Russ.) Available at: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2/2015/6/371997-72982015067.

25. Alekseeva N.S., Ponomareva T.A. Diagnosis of olfactory disorders using the Sniffin Styx test in Parkinson's disease and polypous rhinosinusitis. Vestnik otorinolaringologii = Bulletin otorhinolaryngology. 2014;(1):37-40. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinol aringologii/2014/1/030042-46682014110.

26. Hummel Т., Kobal G., Gudziol H., Mackay-Sim A. Normative data for the “Sniffin Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch ORL. 2007;264(3):237-243. https://doi.org/10.1007/s00405-006-0173-0.

27. Gong S.V., Ahmadi S., Blackburn S.L., Ulin L., Sitar M.J., Long A., Yao W.C. Sniffin' Sticks for measuring olfactory function and recovery after bilateral resection of the upper turbine as part of endoscopic transsphenoidal access. Ann Otol Rhinol Laryngol. 2021;130(6):636-642. https://doi.org/10.1177/0003489420965621.

28. Balungwe P., Hart K., Matanda R., Bisimwa G., Moura A., Rambo P. 3. Adaptation of the Sniffin' Sticks test in South Kivu. Euran Otorhinolaryngol Head Neck Dis. 2020;137(6):467-471. https://doi.org/10.1016/j.anorl.2020.01.012.